SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-01
👔
Lexeo Therapeutics, Inc.
@LXEO_InsiderForm 4 Filing: Otero Jose Manuel Sells $20,903.68 of $LXEO
INSIDER SALE
⚡ MATERIALITY: 4/10
corporate issuer
Lexeo Therapeutics, Inc.
Ticker: $LXEO
Transaction Value
$20,903.68
Price/Share: $1.25
transaction date
2026-07-01
Shares: 16,726
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Otero Jose Manuel, holds the title of Chief Operating Officer at Lexeo Therapeutics, Inc..
On 2026-07-01, the insider transacted 16,726 shares.The shares were transacted at a weighted average price of $1.25 per share, resulting in a total market-relevant value of $20,903.68.
Executive Summary Summary
Otero Jose Manuel (Chief Operating Officer) sold $21K of $LXEO
Post-Transaction Position: 137,482 shares
SEC Accession No: 0002024096-26-000011 (CIK: 2024096)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.